"Il Polo di radioterapia oncologica di via Emilio Longoni, rinnovato anche negli spazi dedicati ai pazienti, è una struttura completamente convenzionata con il Servizio Sanitario Nazionale che occupa una superficie di circa 1400 metri quadrati e garantisce oltre 90mila prestazioni annue, con servizi destinati al bacino di utenza delle regioni del Centro-Sud Italia, oltre a Roma e al Lazio."

During the past decade, Università Campus Biomedico, Via Emilio Longoni, 83 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Università Campus Biomedico, Via Emilio Longoni, 83" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Università Campus Biomedico, Via Emilio Longoni, 83" are "Colon Cancer" (1 trials), "Locally Advanced Pancreatic Cancer" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Università Campus Biomedico, Via Emilio Longoni, 83" in a lesser frequency.

Most popular intervention types in "Università Campus Biomedico, Via Emilio Longoni, 83" are "Drug" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "FOLFOX (Oxaliplatin, 5Fluorouracil, Lederfolin)" (1 trials), "FOLFOX-4" (1 trials), "Gemcitabina, Cisplatino" (1 trials), "Irinotecan/Cetuximab" (1 trials) and "Sorafenib 400 mg po bid, continuously" (1 trials). Other intervention names were less common.

The vast majority of trials in "Università Campus Biomedico, Via Emilio Longoni, 83" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Università Campus Biomedico, Via Emilio Longoni, 83". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Università Campus Biomedico, Via Emilio Longoni, 83, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Università Campus Biomedico, Via Emilio Longoni, 83, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Università Campus Biomedico, Via Emilio Longoni, 83 has several departments that took part in Clinical trials: "Policlinico Universitario Campus Bio-Medico - "Area Ematologia Trapianto Cellule Staminali Medicina Trasfusionale e Terapia cellulare"" - 8 trials, "Policlinico Universitario Campus Biomedico UOC di Oncologia Medica" - 2 trials